These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 21838870)
1. Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors. Malpeli G; Amato E; Dandrea M; Fumagalli C; Debattisti V; Boninsegna L; Pelosi G; Falconi M; Scarpa A BMC Cancer; 2011 Aug; 11():351. PubMed ID: 21838870 [TBL] [Abstract][Full Text] [Related]
2. Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma. Guo W; Cui L; Wang C; Guo Y; Shen S; Kuang G; Dong Z Clin Exp Metastasis; 2014 Jun; 31(5):521-33. PubMed ID: 24756244 [TBL] [Abstract][Full Text] [Related]
3. RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes. Amato E; Barbi S; Fassan M; Luchini C; Vicentini C; Brunelli M; Malleo G; Scarpa A; Malpeli G BMC Cancer; 2016 Jan; 16():11. PubMed ID: 26754001 [TBL] [Abstract][Full Text] [Related]
4. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730 [TBL] [Abstract][Full Text] [Related]
5. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536 [TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells. Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327 [TBL] [Abstract][Full Text] [Related]
8. Aberrant CpG island hypermethylation of RASSF1A in gastric cardia adenocarcinoma. Guo W; Dong Z; Chen Z; Yang Z; Wen D; Kuang G; Guo Y; Shan B Cancer Invest; 2009 May; 27(4):459-65. PubMed ID: 19160099 [TBL] [Abstract][Full Text] [Related]
9. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230 [TBL] [Abstract][Full Text] [Related]
10. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [TBL] [Abstract][Full Text] [Related]
11. Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines. da Costa Prando E; Cavalli LR; Rainho CA Epigenetics; 2011 Dec; 6(12):1413-24. PubMed ID: 22139571 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of the RASSF1A in osteosarcoma. Lim S; Yang MH; Park JH; Nojima T; Hashimoto H; Unni KK; Park YK Oncol Rep; 2003; 10(4):897-901. PubMed ID: 12792742 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma. Klacz J; Wierzbicki PM; Wronska A; Rybarczyk A; Stanislawowski M; Slebioda T; Olejniczak A; Matuszewski M; Kmiec Z Int J Oncol; 2016 Jan; 48(1):55-66. PubMed ID: 26648328 [TBL] [Abstract][Full Text] [Related]
14. The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation. Beckedorff FC; Ayupe AC; Crocci-Souza R; Amaral MS; Nakaya HI; Soltys DT; Menck CF; Reis EM; Verjovski-Almeida S PLoS Genet; 2013; 9(8):e1003705. PubMed ID: 23990798 [TBL] [Abstract][Full Text] [Related]
15. [The Role of 5-Aza-CdR on Methylation of Promoter in RASSF1A Gene in Endometrial Carcinoma]. Huang LP; Chen C; Wang XP; Liu H Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):380-3. PubMed ID: 26121857 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917 [TBL] [Abstract][Full Text] [Related]
17. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277 [TBL] [Abstract][Full Text] [Related]
18. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer. Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473 [TBL] [Abstract][Full Text] [Related]
19. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Dammann R; Takahashi T; Pfeifer GP Oncogene; 2001 Jun; 20(27):3563-7. PubMed ID: 11429703 [TBL] [Abstract][Full Text] [Related]
20. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]